Pomerantz LLP is investigating Johnson & Johnson for potential securities fraud following the company's Q3 2026 report, which showed a net earnings drop to $210 million due to large talc litigation charges and weak MedTech revenue growth. The investigation focuses on whether J&J and its executives engaged in unlawful business practices. The stock fell 5.73% after the earnings miss and revenue challenges in China and the Middle East. Investors affected are encouraged to contact Pomerantz LLP for potential class action participation.
Johnson & Johnson's stock on Pluang trades near its 52-week high at USD 280.78, just shy of the peak at USD 282.11 as of Nov 11, 2026 06:21 WIB, despite the recent earnings challenges noted in the news. The 1-day change of -0.47% contrasts with the article's reported 5.73% drop, indicating some recovery or differing market reactions. Investors on Pluang hold the stock for an average of 130 days, showing moderate-term confidence amid ongoing scrutiny.
A $300,000 investment split equally among Duke Energy, Philip Morris, and Johnson & Johnson generates about $8,590 in annual passive income with a blended yield of 2.86%. Duke Energy offers the highest yield at 3.39%, followed closely by Philip Morri...
Johnson & Johnson announced that CAPLYTA (lumateperone) met primary and key secondary endpoints in a Phase 3 study for treating manic episodes in bipolar I disorder, showing significant symptom improvement as early as Day 3 and sustained through Week...
Following the 2026 midterm elections resulting in a divided U.S. government, four dividend-paying blue-chip stocks—Duke Energy, Procter & Gamble, Johnson & Johnson, and JPMorgan Chase—are highlighted for their resilience amid legislative gridlock. Th...
Johnson & Johnson announced promising Phase 1 results for a novel immunotherapy combining pasritamig and JNJ-9401, targeting two prostate cancer proteins to activate T cells. In the trial, 73% of patients saw PSA levels drop by at least 50%, with nea...
Three dividend stocks from healthcare, real estate, and energy sectors—Johnson & Johnson, Realty Income, and Chevron—stand out for their reliable dividends supported by strong cash flow and manageable debt. Johnson & Johnson boasts 64 years of consec...
